Establishment and characterization of LNCaP-TR-BoM, a bone metastasis-derived prostate cancer cell line with an intermediate AR-attenuated phenotype
This paper establishes and characterizes LNCaP-TR-BoM, a bone metastasis-derived prostate cancer cell line with an intermediate AR-attenuated phenotype, showing transcriptomic and functional similarities to metastatic castration-resistant prostate cancer.
bioRxiv · Oct 6, 2026 · PreprintCancer Biology